Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Vassall

Showing results (121-130 of 167) with videos related to

Pageof 17
Sort By:
Social Science & Medicine (1982)|April 3, 2023
The stated preferences of community-based volunteers for roles in the prevention of violence against women and girls in Ghana: A discrete choice analysisNikita Arora, Romain Crastes Dit Sourd, Matthew Quaife, et al.
PLOS Global Public Health|March 24, 2023
What, how and who: Cost-effectiveness analyses of COVID-19 vaccination to inform key policies in NigeriaFrancis J Ruiz, Sergio Torres-Rueda, Carl A B Pearson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2008
Cost-effectiveness analysis of introduction of rapid, alternative methods to identify multidrug-resistant tuberculosis in middle-income countriesCarlos Acuna-Villaorduna, Anna Vassall, German Henostroza, et al.
Plos One|May 2, 2015
The Costs of Delivering Integrated HIV and Sexual Reproductive Health Services in Limited Resource SettingsCarol Dayo Obure, Sedona Sweeney, Vanessa Darsamo, et al.
Pharmacoeconomics|May 5, 2020
A Systematic Review of Methodological Variation in Healthcare Provider Perspective Tuberculosis Costing Papers Conducted in Low- and Middle-Income Settings, Using An Intervention-Standardised Unit Cost TypologyLucy Cunnama, Gabriela B Gomez, Mariana Siapka, et al.
Trials|July 27, 2018
Evaluation of a medication monitor-based treatment strategy for drug-sensitive tuberculosis patients in China: study protocol for a cluster randomised controlled trialJames J Lewis, Xiaoqiu Liu, Zhiying Zhang, et al.
International Journal of Health Policy and Management|August 5, 2024
The Use of Evidence-Informed Deliberative Processes for Designing the Essential Package of Health Services in PakistanRob Baltussen, Maarten Jansen, Syeda Shehirbano Akhtar, et al.
Pharmacoeconomics|May 29, 2020
Correction to: A Systematic Review of Methodological Variation in Healthcare Provider Perspective Tuberculosis Costing Papers Conducted in Low- and Middle-Income Settings, Using An Intervention-Standardised Unit Cost TypologyLucy Cunnama, Gabriela B Gomez, Mariana Siapka, et al.
BMJ Global Health|May 27, 2021
Exploring equity in health and poverty impacts of control measures for SARS-CoV-2 in six countriesSedona Sweeney, Theo Prudencio Juhani Capeding, Rosalind Eggo, et al.
BMJ Public Health|March 11, 2026
Cost-effectiveness of cancer interventions in Rwanda: literature review and expert elicitation for health benefits package designCassandra Nemzoff, Andres Madriz-Montero, Inga Mumukunde, et al.
Pageof 17

Showing results (121-130 of 167) with videos related to

Sort By:
Pageof 17
Social Science & Medicine (1982)|April 3, 2023
The stated preferences of community-based volunteers for roles in the prevention of violence against women and girls in Ghana: A discrete choice analysisNikita Arora, Romain Crastes Dit Sourd, Matthew Quaife, et al.
PLOS Global Public Health|March 24, 2023
What, how and who: Cost-effectiveness analyses of COVID-19 vaccination to inform key policies in NigeriaFrancis J Ruiz, Sergio Torres-Rueda, Carl A B Pearson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2008
Cost-effectiveness analysis of introduction of rapid, alternative methods to identify multidrug-resistant tuberculosis in middle-income countriesCarlos Acuna-Villaorduna, Anna Vassall, German Henostroza, et al.
Plos One|May 2, 2015
The Costs of Delivering Integrated HIV and Sexual Reproductive Health Services in Limited Resource SettingsCarol Dayo Obure, Sedona Sweeney, Vanessa Darsamo, et al.
Pharmacoeconomics|May 5, 2020
A Systematic Review of Methodological Variation in Healthcare Provider Perspective Tuberculosis Costing Papers Conducted in Low- and Middle-Income Settings, Using An Intervention-Standardised Unit Cost TypologyLucy Cunnama, Gabriela B Gomez, Mariana Siapka, et al.
Trials|July 27, 2018
Evaluation of a medication monitor-based treatment strategy for drug-sensitive tuberculosis patients in China: study protocol for a cluster randomised controlled trialJames J Lewis, Xiaoqiu Liu, Zhiying Zhang, et al.
International Journal of Health Policy and Management|August 5, 2024
The Use of Evidence-Informed Deliberative Processes for Designing the Essential Package of Health Services in PakistanRob Baltussen, Maarten Jansen, Syeda Shehirbano Akhtar, et al.
Pharmacoeconomics|May 29, 2020
Correction to: A Systematic Review of Methodological Variation in Healthcare Provider Perspective Tuberculosis Costing Papers Conducted in Low- and Middle-Income Settings, Using An Intervention-Standardised Unit Cost TypologyLucy Cunnama, Gabriela B Gomez, Mariana Siapka, et al.
BMJ Global Health|May 27, 2021
Exploring equity in health and poverty impacts of control measures for SARS-CoV-2 in six countriesSedona Sweeney, Theo Prudencio Juhani Capeding, Rosalind Eggo, et al.
BMJ Public Health|March 11, 2026
Cost-effectiveness of cancer interventions in Rwanda: literature review and expert elicitation for health benefits package designCassandra Nemzoff, Andres Madriz-Montero, Inga Mumukunde, et al.
Pageof 17